Visit

Valuation

IP-focused arbitration centre seeks to head off legal disputes caused by pandemic

Many court dockets are on hold, but IP disputes are not. Ocean Tomo and the International Arbitration Centre Tokyo think ADR can help bridge the gap

27 Mar 2020

From the IAM archive – corporate IP success stories

The inside story on how TD Bank, Dolby Labs, LinkedIn, Siam Cement, Rockwell Collins and Google built strategies to maximise the value of their assets

26 Mar 2020

Final call to take part in this year’s IAM benchmarking survey

Help us to identify the key trends currently shaping the global IP market

Latest

View all

23 Mar 2020

Nokia made over $1 billion from licensing in 2019, but maybe it could have been more

Analysis of the Finnish companies’ annual reports, alongside developments in the overall market for mobile technology, indicate there could be further royalty upside for the telecoms giant Read more

20 Mar 2020

Fortress may have struck gold with its Theranos patents

Data analysis reveals that the IP portfolio created by Elizabeth Holmes’ now defunct company is of high-quality and has widespread geographic coverage Read more

19 Mar 2020

Final call for IP Hall of Fame 2020 nominations

You have until the end of the week to put forward names for consideration Read more

18 Mar 2020

Help us map the latest developments in the global IP market

There’s not long left to answer our annual IP benchmarking survey Read more

News

View all

6 Mar 2020

Notice of postponement - IPBC Europe 2020 and IP Risk Management Europe 2020

New dates for both events, which had been scheduled to take place in the last week of March, will be announced as soon as possible Read more

18 Feb 2020

Tell us what you think of the latest developments in the global IP market

IAM's annual IP benchmarking survey opens today Read more

6 Feb 2020

Key takeaways from IAM’s 2020 Pharma and Biotech IP event

The UPC, the rise of AI, international patent litigation and pharma patent dealmaking were among the hot topics discussed at this year’s conference Read more

1 Feb 2020

We need better thinking on US pharma patent reforms

As the presidential race heats up - and with even self-styled Democrat centrist Michael Bloomberg now promising radical regime change - life sciences IP professionals must interject some sanity into the debate Read more

Analysis

View all

17 Mar 2020

How to secure IP litigation funding in the pharma and biotech sectors

Leading players in this evolving space tell IAM about trends in the biopharma industry and advise on how best to get investment Read more

10 Mar 2020

The key IP takeaways from medtech’s largest buyout in years

Thermo Fisher has agreed to spend $11.5 billion on Qiagen to acquire complementary diagnostics and bioinformatics assets Read more

6 Mar 2020

A rapid analysis of Intel’s connected devices patent portfolio

After $1 billion Apple deal, attention turns to second stockpile of assets which chipmaker has put on the market Read more

6 Mar 2020

AbbVie’s purchase of Allergan expands patent scope

The acquisition is a play by the Illinois-based pharma giant to mitigate the impact of losing exclusivity of Humira, but it also gives it strength in underrepresented areas of its portfolio Read more

Insights

View all

1 Oct 2017

A round-up of IP-related quotes, observations and opinions from the recent past …

30 Sep 2016

McRO gives hope to US patent owners, but Section 101 uncertainty remains

After two years of uncertainty and no little gloom, a recent Federal Circuit decision may just herald the long-awaited swing-back in the pendulum that software patent owners in the United States have been waiting for. Some, though, still believe that Congress must bite the bullet and take a look at Section 101 Read more

1 Aug 2016

Brexit leaves the UPC in limbo – and that’s no bad thing

The UK vote to leave the European Union may have surprised and disappointed many in the IP community, but a rush to bypass the decision and implement the unitary patent package would be a mistake

31 Jul 2015

A perfect storm means that Europe now has the chance to lead

While legislators and the courts conspire to make life ever harder for patent owners in the United States, across the Atlantic imminent changes are taking the narrative in the opposite direction. This all means that Europe has a historic opportunity to assume global patent leadership

Twitter

31 Mar 2020

@IAM_magazine How the US patent dispute system is responding to covid-19 https://t.co/TRKiEPew2j https://t.co/vE4ytQWeIt Read more

31 Mar 2020

@IAM_magazine Nearly 100 products, newly classified as biologics, face competition from imitators for the first time. Teva sues F… https://t.co/QOelFnAm2p Read more

31 Mar 2020

@IAM_magazine RT @patentology: Frankly, this is utopian nonsense. If we, as a global community, can't solve a global problem without asking #IP owners to… Read more

30 Mar 2020

@IAM_magazine "It isn't perfect but it's something" - launch of Covid-19 patent pledge attracts some serious backers and gives ri… https://t.co/yLETnySzw1 Read more

Find an expert

Michael Schramm

Attorney at Law

Munich, Germany

2s-ip Schramm Schneider Bertagnoll Patent- und Rechtsanwälte Part mbB

View full biography